Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. (2012)

First Author: Chaidos A
Attributed to:  Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2011-11-389304

PubMed Identifier: 22371885

Publication URI: http://europepmc.org/abstract/MED/22371885

Type: Journal Article/Review

Volume: 119

Parent Publication: Blood

Issue: 21

ISSN: 0006-4971